A FIRST-of-its-kind pill designed to transform treatment of agonising endometriosis will be available on the NHS.
The condition affects an estimated 1.5 million women in the UK, causing intense pain, fatigue and heavy bleeding.
GettyEndometriosis affects millions of women in the UK[/caption]The drug – known as relugolix combination therapy or Ryeqo – was approved by the National Institute for Health and Care Excellence (NICE) for NHS use.
This is the first long-term...
Заголовки